Tag: Lead Story
Capital Good Fund to expand services with $466K Treasury grant
PROVIDENCE – The Capital Good Fund has received its largest influx of funding ever with a $466,000 grant from the U.S. Treasury, which will...
Tvar EdTech wins grand prize at Get Started R.I. business pitch...
PROVIDENCE – Wednesday evening, Rhode Island’s entrepreneurs brought a slice of Silicon Valley to the Waterfire Arts Center in Providence with the annual “Get...
Emerald Square mall converting to a retail-office mix
NORTH ATTLEBOROUGH – The Emerald Square mall is undergoing a conversion in identity, from a place to shop, to a place to shop –...
Brown endowment hits $3.5B
PROVIDENCE - Brown University's endowment rose to $3.5 billion by the end of the 2017 fiscal year - a 13.4 percent increase year over...
DOR: August revenue outpaces budget estimate
PROVIDENCE – Rhode Island’s August revenue of $268.4 million outpaced fiscal 2018 budget estimates by 2.2 percent, or $5.8 million, according to a report...
Noyce, Keefe lead honorees in PBN’s 2017 Business Excellence Awards
PROVIDENCE — Kurt Noyce, president of Embrace Home Loans, recently named the fastest-growing private company with revenue greater than $75 million by Providence Business...
Invenergy reaches deal with Narragansett Indian Tribe for water supply
BURRILLVILLE – Invenergy Thermal Development LLC reached deals Thursday with the Narragansett Indian Tribe and Benn Water & Heavy Transport to satisfy the company’s...
Brown ranks No. 11 on WSJ U.S. college rankings
PROVIDENCE – Brown University ranked No. 11, tied with the University of Chicago, in the 2018 Wall Street Journal/Times Higher Education rankings of United...
Washington Trust CEO, CFO to retire
WESTERLY – There’s a changing of the guard planned this winter for Washington Trust Bancorp Inc., as long-time Chairman and CEO Joseph J. MarcAurele...
EpiVax launches EpiVax Oncology for personalized cancer vaccines
PROVIDENCE — Immunolgy engineering biotech firm EpiVax Inc. has launched EpiVax Oncology Inc., a venture-backed spinoff focused on the development of personalized therapeutic cancer...


















